Efficacy and safety of Tripterygium wilfordii glycosides tablets combined with Western medicine for patients with rheumatic immune diseases

Table 2 Subgroup analysis results of Tripterygium wilfordii glycosides tablets combined with Western medicine in treatment of different rheumatic immune disease

Subgroup	Relative risk	95%CI	P value
Rheumatoid arthritis	1.12	1.02-1.24	< 0.05
Systemic lupus erythematosus	1.05	0.93-1.18	0.45
Sjögren's syndrome	1.10	0.98-1.24	0.10
Treatment duration (≤ 12 wk)	1.08	1.01-1.16	< 0.05
Treatment duration (> 12 wk)	1.05	0.95-1.15	0.30